Upadacitinib in the treatment of Takayasu Arteritis: a case report on new perspectives on targeted immunomodulation
Rheumatology (Oxford)
.
2025 May 23:keaf279.
doi: 10.1093/rheumatology/keaf279.
Online ahead of print.
Authors
Alexander Pfeil
1
,
Wiebke Schulze
1
,
Ulf Teichgräber
2
,
Tobias Hoffmann
1
,
Niklas Eckardt
2
,
Christian Geis
3
,
Falk Gühne
4
,
Martin Freesmeyer
4
,
Gunter Wolf
1
,
Albrecht Günther
3
Affiliations
1
Department of Internal Medicine III, Jena University Hospital-Friedrich-Schiller-University Jena, Am Klinikum 1, Jena, Germany.
2
Institute for Diagnostic and Interventional Radiology, Jena University Hospital-Friedrich-Schiller-University Jena, Am Klinikum 1, Jena, Germany.
3
Department of Neurology, Jena University Hospital-Friedrich-Schiller-University Jena, Am Klinikum 1, Jena, Germany.
4
Clinic of Nuclear Medicine, Jena University Hospital-Friedrich-Schiller-University Jena, Am Klinikum 1, Jena, Germany.
PMID:
40408238
DOI:
10.1093/rheumatology/keaf279
No abstract available